ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Nasal Polyps
Rhinosinusitis
Allergic Rhinitis
Rhinitis
Chronic Obstructive Pulmonary Disease
Lung Diseases

Asthma trials near Barcelona, CT, ESP:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Barcelona, Spain and 83 other locations

This is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma...

Active, not recruiting
Asthma
Biological: Tezepelumab

Phase 3

AstraZeneca
AstraZeneca

Barcelona, Spain and 76 other locations

compared with placebo in participants with moderate-to-severe asthma.Study details include:* The study duration for each participant will be...

Enrolling
Asthma
Drug: Placebo to AZD4604
Drug: AZD4604

Phase 2

AstraZeneca
AstraZeneca

Barcelona, Spain and 24 other locations

12 years old with moderate to severe asthma....

Enrolling
Asthma
Drug: Glycopyrronium bromide 25ug
Drug: Glycopyrronium bromide 12.5ug

Phase 2

Novartis
Novartis

Barcelona, Catalunya, Spain and 20 other locations

Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...

Active, not recruiting
Asthma
Drug: Asthma reliever therapies
Drug: Asthma controller therapies (incl. prednisone/prednisolone)

Phase 3

Sanofi
Sanofi

Barcelona, Barcelona [Barcelona], Spain and 79 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Barcelona, Spain and 114 other locations

to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...

Enrolling
Asthma
Drug: QMF149
Drug: Budesonide

Phase 3

Novartis
Novartis

Barcelona, Catalunya, Spain and 51 other locations

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Enrolling
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

Phase 2

Incyte
Incyte

Barcelona, Spain and 92 other locations

BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...

Enrolling
Asthma
Drug: AZD4604
Other: Placebo

Phase 2

AstraZeneca
AstraZeneca

Barcelona, Spain and 158 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Barcelona, Barcelona [Barcelona], Spain and 52 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems